Group One Trading
BCLI

Group One Trading’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Group One Trading’s Portfolio BCLI Stock Details BCLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,117
Closed -$5.76K – 7263
2024
Q3 		$10.8K Hold
3,117
– – ﹤0.01% 5566
2024
Q2 		$15.8K Buy
3,117
+1,073
+52% +$8.05K ﹤0.01% 5375
2024
Q1 		$17.3K Buy
2,044
+441
+28% +$2.42K ﹤0.01% 5533
2023
Q4 		$6.56K Sell
1,603
-4,870
-75% -$14.6K ﹤0.01% 6404
2023
Q3 		$19.4K Buy
+6,473
New +$147K ﹤0.01% 5907
2023
Q2 		– Sell
-10,850
Closed -$450K – 7640
2023
Q1 		$537K Buy
10,850
+9,718
+858% +$282K ﹤0.01% 2711
2022
Q4 		$27.8K Buy
+1,132
New +$42.3K ﹤0.01% 5395
2022
Q3 		– Sell
-1,609
Closed -$80.7K – 7543
2022
Q2 		$67K Sell
1,609
-1,664
-51% -$74.9K ﹤0.01% 5316
2022
Q1 		$165K Buy
+3,273
New +$161K ﹤0.01% 5004
2021
Q2 		– Sell
-4,434
Closed -$237K – 8132
2021
Q1 		$255K Sell
4,434
-2,482
-36% -$187K ﹤0.01% 4763
2020
Q4 		$469K Buy
+6,916
New +$942K ﹤0.01% 3320
2020
Q1 		– Sell
-3,004
Closed -$234K – 5254
2019
Q4 		$193K Sell
3,004
-5,427
-64% -$315K ﹤0.01% 3198
2019
Q3 		$493K Buy
8,431
+1,015
+14% +$59.9K ﹤0.01% 2345
2019
Q2 		$439K Buy
7,416
+4,294
+138% +$250K ﹤0.01% 2237
2019
Q1 		$203K Buy
3,122
+2,451
+365% +$139K ﹤0.01% 2694
2018
Q4 		$36K Buy
+671
New +$33.1K ﹤0.01% 3721
2017
Q3 		– Sell
-40
Closed -$2.59K – 4817
2017
Q2 		$3K Sell
40
-105
-72% -$6.47K ﹤0.01% 4508
2017
Q1 		$9K Buy
+145
New +$7.55K ﹤0.01% 4143
2016
Q1 		– Sell
-259
Closed -$11K – 4555
2015
Q4 		$11K Hold
259
– – ﹤0.01% 4143
2015
Q3 		$9K Sell
259
-33
-11% -$1.55K ﹤0.01% 4328
2015
Q2 		$16K Buy
+292
New +$17.4K ﹤0.01% 4131

Other funds holding BCLI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LWM
Liberty Wealth Management Oakland, California $800M AUM 20.44% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Group One Trading's BCLI Position: Q4 2024 in Review

Group One Trading sold out of BRAINSTORM CELL THERAPUTC (BCLI) in Q4 2024, closing a stake of 3,117 shares — an estimated $5.76K sold.

Group One Trading first reported a position in BCLI in Q2 2015 and held it in 21 quarters. The position peaked at $537K in Q1 2023. 34 funds tracked by Wall St. Rank hold BCLI as of Q4 2024.

  • Group One Trading reported no remaining BRAINSTORM CELL THERAPUTC position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 3,117 BRAINSTORM CELL THERAPUTC shares in Q4 2024, an estimated $5.76K.
  • Group One Trading first reported a position in BRAINSTORM CELL THERAPUTC in Q2 2015 and held it in 21 quarters.
  • Group One Trading's BRAINSTORM CELL THERAPUTC position peaked at $537K in Q1 2023.
  • 34 funds tracked by Wall St. Rank held BRAINSTORM CELL THERAPUTC as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.